leuprolide


Also found in: Dictionary, Wikipedia.
Related to leuprolide: leuprolide acetate

leuprolide

 [loo-pro´līd]
a synthetic analogue of gonadotropin-releasing hormone, used in the form of the acetate ester as an antineoplastic agent, treatment for endometriosis, and gonadotropin inhibitor. Administered subcutaneously or intramuscularly.

leuprolide

(lo͞o′prō-līd′)
n.
A drug that is a synthetic polypeptide analog of naturally occurring gonadotropin-releasing hormone, C29H84N16O12, used in its acetate form to treat advanced prostate cancer.

leuprolide

Viadur® An analogue of gonadotropin-releasing hormone, which has been used to manage PMS, and block ovarian or testicular hormone production in Pts with hormonally active CA. See PMS.
References in periodicals archive ?
Prescribing leuprolide to treat a paraphilic disorder falls under FDA guidelines regarding the use of an approved drug for an "off-label" indication, and therefore is not considered investigational.
At current prices, elagolix treatment is substantially less expensive than treatment with leuprolide or nafarelin.
Leuprolide was chosen based on the ability to manipulate circulating testosterone levels, decreased side effects compared to diethylstilbestrol, convenient dosing, and the ability to titrate the medication.
Dolinko and Ginsburg presented a similar case of a 69-year-old woman where they failed to locate the elevated androgen source and the patient was treated with leuprolide [9].
Vazquez et al., "Ulipristal acetate versus leuprolide acetate for uterine fibroids," New England Journal of Medicine, vol.
After 4 weeks of administration of leuprolide, depressive symptoms had developed among most of the women in the study.
One of the patients used triptorelin acetate and the others used leuprolide acetate.
This turkey was treated with the same regimen of leuprolide acetate and deslorelin acetate implants at the same time intervals as the turkey in case 1.
KEY WORDS: Abnormal uterine bleeding, leiomyoma, leukemia, leuprolide acetate
Head of Iran's Polymer and Petrochemical Institute Mehdi Nekoumanesh, while announcing the unveiling process of leuprolide acetate, said it is a one-month injecting drug for prostate cancer which is the same as the American drug with the same application, the MNA said in a report.
In order to shrink the tumor in her genito pelvic region so that it could be extirpated with the highest likelihood of success, the patient was treated with gonadotropin-releasing hormone agonist (leuprolide acetate, 3.75 mg/month for 4 months).